Subchondroplasty in the treatment of subchondral bone marrow edema: a bibliometric analysis
Keywords:
subchondroplasty, osteoarthritis, subchondral bone marrow edema, bibliometrics, ScopusAbstract
Background and objective: Osteoarthritis is one of the most prevalent causes of disability worldwide. The presence of subchondral bone marrow edema has a negative prognostic significance in the evolution of osteoarthritis. A novel approach, called subchondroplasty, has been proposed to address the subchondral bone marrow edema, stimulate the subchondral metabolism, and prevent osteoarthritis evolution. This study aimed to investigate the research status concerning subchondroplasty by a bibliometric methodology. Methods: Publications about the use of subchondroplasty from 2012 to 2022 were searched from the Scopus database. A bibliometric analysis of the dataset was conducted by using a statistical-descriptive spreadsheet tool and the Bibliometrix® software. Results: In total, 121 articles, published from 2012 to 2022 met the criteria and were included in this study. The number of publications concerning subchondroplasty progressively increased since 2014 with an annual growth rate of 35.11%. The country with the highest rate of publications was the United States (about 60% of the overall production). The most productive journal is “Arthroscopy Techniques” while the most cited source is “Osteoarthritis and Cartilage”. The most productive scholars were Elizaveta Kon, Steven Brad Cohen, and Peter Sharkey. Conclusion: This study analyses the scientific production over time concerning the use of subchondroplasty for the management of subchondral bone marrow edema. It is still a niche topic, with a modest scientific production but this is only a starting point. The promising results of subchondroplasty should be confirmed by higher-quality studies to better understand which patients might concretely benefit from this procedure.
References
Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013; 21(9):1145-53. doi: 10.1016/j.joca.2013.03.018.
Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003; 139(5 Pt 1):330–6. doi: 10.7326/0003-4819-139-5_part_1-200309020-00008.
Muratovic D, Findlay DM, Cicuttini FM, Wluka AE, Lee YR, Kuliwaba JS. Bone matrix microdamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis. Bone. 2018; 108:193–201. doi: 10.1016/j.bone.2018.01.012.
Alliston T, Hernandez CJ, Findlay DM, Felson DT, Kennedy OD. Bone marrow lesions in osteoarthritis: what lies beneath. J Orthop Res. 2018; 36(07):1818–25. doi: 10.1002/jor.23844.
Sharkey PF, Cohen SB, Leinberry CF, Parvizi J. Subchondral bone marrow lesions associated with knee osteoarthritis. Am J Orthop. 2012; 41(09):413–7. PMID: 23365809.
Colon DA, Yoon BV, Russell TA, Cammisa FP, Abjornson C. Assessment of the injection behavior of commercially available bone BSMs for Subchondroplasty(R) procedures. Knee. 2015; 22(6):597–603. doi: 10.1016/j.knee.2015.06.017.
Diodato VP, Gellatly P. Dictionary of Bibliometrics, Routledge, Amazon Digital Services, Inc. New York, 2013; 204.
Aria M, Cuccurullo C. Bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of Informetrics. 2017; 11(4): 959-75. doi: 10.1016/j.joi.2017.08.007.
Kon E, Ronga M, Filardo G, et al. Bone marrow lesions and subchondral bone pathology of the knee. Knee Surg Sports Traumatol Arthrosc. 2016; 24:1797–1814. doi: 10.1007/s00167-016-4113-2.
Cohen SB, Sharkey PF. Subchondroplasty for treating bone marrow lesions. J Knee Surg. 2016; 29(7):555–63. doi: 10.1055/s-0035-1568988.
Escobar Ivirico JL, Bhattacharjee M, Kuyinu E, Nair LS, Laurencin CT. Regenerative Engineering for Knee Osteoarthritis Treatment: Biomaterials and Cell-Based Technologies. Engineering (Beijing). 2017; 3(1):16-27. doi: 10.1016/j.eng.2017.01.003.
Farr J, Cohen SB. Expanding applications of the subchondroplasty procedure for the treatment of bone marrow lesions observed on magnetic resonance imaging. Oper Tech Sports Med. 2013; 21:138–43. doi: 10.1053/j.otsm.2013.03.006.
Chatterjee D, McGee A, Strauss E, Youm T, Jazrawi L. Subchondral Calcium Phosphate is Ineffective for Bone Marrow Edema Lesions in Adults With Advanced Osteoarthritis. Clin Orthop Relat Res. 2015; 473(7):2334-42. doi: 10.1007/s11999-015-4311-0.
Ogura T, Ackermann J, Mestriner AB, Merkely G, Gomoll AH. The Minimal Clinically Important Difference and Substantial Clinical Benefit in the Patient-Reported Outcome Measures of Patients Undergoing Osteochondral Allograft Transplantation in the Knee. Cartilage. 2021; 12(1):42-50. doi: 10.1177/1947603518812552.
Byrd J, Akhavan S, Frank D, DeMeo P. Short and mid-term outcomes of the subchondroplasty procedure for the treatment of bone marrow in patients with knee osteoarthritis. Arthrosc J Arthrosc Relat Surg. 2017; 33(6):e32.
Davis AT, Byrd JM, Zenner JA, Frank DA, DeMeo PJ, Akhavan S. Short-Term Outcomes of the Subchondroplasty Procedure for the Treatment of Bone Marrow Edema Lesions in Patients with Knee Osteoarthritis. Orthop J Sports Med. 2015; 3(7_suppl2). doi:10.1177/2325967115S00125
Hajnik C, Akhavan S, Wyland DJ, et al. Two year clinical outcomes of the Subchondroplasty® procedure for treatment of symptomatic bone marrow lesions of the knee. Orthop J Sports Med. 2019; 29; 7(7 suppl5):2325967119S00291. doi:10.1177/2325967119S00291.
Nairn LN, Subramaniam M, Ekhtiari S, Axelrod DE, Grant JA, Khan M. Safety and early results of Subchondroplasty® for the treatment of bone marrow lesions in osteoarthritis: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2021; 29(11):3599-607. doi: 10.1007/s00167-020-06294-w.
Plana NM, Massie JP, Bekisz JM, Spore S, Diaz-Siso JR, Flores RL. Variations in databases used to assess academic output and citation impact. N Engl J Med. 2017;376(25):2489-91. doi: 10.1056/NEJMc1616626.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Michele Venosa, Irene Schettini, Massimo Angelozzi, Emilio Romanini, Gianpiero Cazzato, Vittorio Calvisi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
